OGEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ogen, and what generic alternatives are available?
Ogen is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs.
The generic ingredient in OGEN is estropipate. There are two drug master file entries for this compound. Additional details are available on the estropipate profile page.
Summary for OGEN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Patent Applications: | 2,933 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OGEN at DailyMed |
US Patents and Regulatory Information for OGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | OGEN | estropipate | CREAM;VAGINAL | 084710-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | OGEN 2.5 | estropipate | TABLET;ORAL | 083220-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | OGEN .625 | estropipate | TABLET;ORAL | 083220-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | OGEN 1.25 | estropipate | TABLET;ORAL | 083220-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |